Yang, X.; Lin, R.; Feng, C.; Kang, Q.; Yu, P.; Deng, Y.; Jin, Y.
Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration. Pharmaceutics 2024, 16, 1353.
https://doi.org/10.3390/pharmaceutics16111353
AMA Style
Yang X, Lin R, Feng C, Kang Q, Yu P, Deng Y, Jin Y.
Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration. Pharmaceutics. 2024; 16(11):1353.
https://doi.org/10.3390/pharmaceutics16111353
Chicago/Turabian Style
Yang, Xinxin, Ruiting Lin, Changzhuo Feng, Qiyuan Kang, Peng Yu, Yongzhi Deng, and Ye Jin.
2024. "Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration" Pharmaceutics 16, no. 11: 1353.
https://doi.org/10.3390/pharmaceutics16111353
APA Style
Yang, X., Lin, R., Feng, C., Kang, Q., Yu, P., Deng, Y., & Jin, Y.
(2024). Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration. Pharmaceutics, 16(11), 1353.
https://doi.org/10.3390/pharmaceutics16111353